Protalix Biotherapeutics Inc (NYSE American:PLX)
| 1.23 Delayed Data As of Aug 12 |  +0.005 / +0.41%Today’s Change | 0.70 Today|||52-Week Range 2.00 | +47.89% Year-to-Date |
Latest PLX News | Press Releases
No recent news for Protalix Biotherapeutics Inc.
Today’s Trading
| Previous close | 1.23 |
| Today’s open | 1.22 |
| Day’s range | 1.22 - 1.23 |
| Volume | 99,318 |
| Average volume (3 months) | 2,644,636 |
| Market cap | $57.7M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -179.22% |
| Earnings growth (this year) | +11.29% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -39.03% |
| P/E ratio | NM |
| Price/Sales | 0.96 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASLNAslan Pharmaceutical... | +0.16 | +22.91% |
| SYRSSyros Pharmaceutical... | +0.03 | +2.70% |
| MDNAMedicenna Therapeuti... | +0.07 | +7.00% |
| CBIOCatalyst Biosciences... | +0.06 | +3.23% |
Data as of 4:00pm ET, 08/12/2022
Financials
| Last reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.18 |
| Annual revenue (last year) | $38.4M |
| Annual profit (last year) | -$27.6M |
| Net profit margin | -71.92% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Hackensack, New Jersey |
Forecasts
